STOKStoke Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Stoke Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOKEsta | $1.8B#8 | — | 5.2x#9 | 9.8x#4 | 404.5%#4 | 92.3%#2 | -11.2%#4 | -2.0%#5 | — | — | 20.6%#6 | — |
| NUVB | $2.0B#1 | — | 8.0x#10 | 32.3x#8 | 699.0%#2 | 64.0%#4 | -338.7%#10 | -80.6%#12 | -87.4%#5 | — | — | — |
| GENB | $2.0B#2 | — | 4.4x#6 | — | — | — | — | 0.0%#2 | — | — | — | — |
| RAPP | $2.0B#3 | — | 4.7x#8 | — | — | -42.4%#11 | — | -26.4%#9 | — | — | — | — |
| AGIO | $2.0B#4 | — | 1.9x#3 | 36.4x#9 | 48.0%#7 | -161.3%#12 | -873.9%#11 | -40.3%#10 | — | — | — | — |
| PRGO | $1.9B#5 | — | 0.7x#1 | 0.4x#1 | -2.8%#11 | -729.7%#13 | -26.4%#5 | -56.7%#11 | -20.9%#3 | 4#1 | -30.5%#10 | 8.5%#1 |
| ZYME | $1.9B#6 | — | 23.1x#11 | 17.6x#6 | 38.9%#9 | 33.9%#6 | -87.3%#6 | -100.9%#13 | — | — | 65.5%#5 | — |
| BHVN | $1.8B#7 | — | 148.4x#15 | — | — | 12.7%#8 | — | -6045.0%#16 | — | — | -18.4%#8 | — |
| SEPN | $1.8B#9 | — | 4.6x#7 | 39.0x#10 | 4174.5%#1 | 31.9%#7 | -148.6%#8 | -12.6%#7 | — | — | 165.5%#3 | — |
| XNCR | $1.8B#10 | — | 3.5x#5 | 14.0x#5 | 13.7%#10 | 60.5%#5 | -141.4%#7 | -18.3%#8 | -31.5%#4 | — | 155.2%#4 | — |
| ANIP | — | 16.1x#1 | — | — | 43.8%#8 | 510.5%#1 | 12.6%#2 | 13.1%#1 | 16.9%#1 | — | -24.5%#9 | — |
| KLRA | $1.6B#11 | — | 1.5x#2 | — | — | — | — | 0.0%#2 | — | — | — | — |
| KARD | $1.6B#12 | — | 2.6x#4 | — | — | — | — | 0.0%#2 | — | — | — | — |
| ETON | $1.6B#13 | — | 34.6x#12 | 20.1x#7 | 104.9%#6 | -20.4%#10 | -1.1%#3 | -9.9%#6 | -1.8%#2 | 4#1 | 220.3%#1 | — |
| ANAB | $1.6B#14 | — | 124.0x#14 | 6.7x#2 | 157.0%#5 | 90.9%#3 | 20.4%#1 | -103.8%#14 | — | — | 180.0%#2 | — |
| SNDX | $1.5B#15 | — | 102.1x#13 | 8.9x#3 | 627.8%#3 | 10.5%#9 | -158.4%#9 | -1890.2%#15 | -1205.8%#6 | — | 14.9%#7 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice